Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, Q2 2026
25,502
Period ended Jun 30, 2026
Change on a year earlier
+24.5%
20,476 in Q2 2025
History
63 quarters
Since Q4 2008
Sources
61
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total current liabilities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 25,502 | +24.5% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 24,955 | +8.5% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 25,489 | +10.3% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 21,791 | +7.3% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 20,476 | -4.8% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 23,008 | +16.7% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 23,099 | +25.6% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2024 | Sep 30, 2024 | 20,312 | +19.8% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 21,517 | +25.9% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 19,714 | +38.7% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 18,392 | +17.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | 16,954 | +18.3% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | 17,097 | +35.5% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 14,215 | +10.3% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 15,687 | +28.8% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2022 | Sep 30, 2022 | 14,331 | -3.4% | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | 12,618 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 12,886 | +0.1% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | 12,184 | +4.6% | Form 10-K (filed 2022-02-16) ↗ |
| Q3 2021 | Sep 30, 2021 | 14,842 | +49.1% | Form 10-Q (filed 2021-11-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 12,869 | +8.8% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | 11,653 | -9.2% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 9,953 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | 10,523 | -0.9% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 11,827 | -6.9% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 12,835 | -4.8% | Form 10-K (filed 2020-02-12) ↗ |
| Q2 2019 | Jun 30, 2019 | 10,622 | -5.2% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 12,706 | +21.3% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 13,488 | +49.5% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 12,432 | +51.7% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 11,205 | +43.4% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | 10,479 | -0.4% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | 9,020 | -19.5% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 8,193 | -22.3% | Form 10-Q (filed 2017-10-26) ↗ |
| Q2 2017 | Jun 30, 2017 | 7,815 | -27.8% | Form 10-Q (filed 2017-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | 10,523 | +23.5% | Form 10-Q (filed 2017-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | 11,204 | +29.3% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2016 | Sep 30, 2016 | 10,542 | +47.1% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 10,830 | +57.2% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2016 | Mar 31, 2016 | 8,523 | +34.5% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2015 | Dec 31, 2015 | 8,664 | +23.6% | Form 10-Q (filed 2016-05-02) ↗ |
| Q3 2015 | Sep 30, 2015 | 7,165 | -16.2% | Form 10-Q (filed 2015-11-02) ↗ |
| Q2 2015 | Jun 30, 2015 | 6,891 | -12.4% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 6,336 | -22.8% | Form 10-Q (filed 2015-04-27) ↗ |
| Q4 2014 | Dec 31, 2014 | 7,008 | -11.8% | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | 8,551 | +76.6% | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 7,866 | – | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 8,203 | +59.5% | Form 10-Q (filed 2014-04-30) ↗ |
| Q4 2013 | Dec 31, 2013 | 7,947 | -3.0% | Form 10-K (filed 2014-02-24) ↗ |
| Q3 2013 | Sep 30, 2013 | 4,843 | -42.1% | Form 10-Q (filed 2013-10-29) ↗ |
| Q1 2013 | Mar 31, 2013 | 5,142 | – | Form 10-Q (filed 2013-05-03) ↗ |
| Q4 2012 | Dec 31, 2012 | 8,191 | +42.4% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 8,367 | – | Form 10-Q (filed 2012-11-06) ↗ |
| Q4 2011 | Dec 31, 2011 | 5,754 | -12.4% | Form 10-K (filed 2012-02-29) ↗ |
| Q1 2011 | Mar 31, 2011 | 4,249 | -35.2% | Form 10-Q (filed 2011-05-10) ↗ |
| Q4 2010 | Dec 31, 2010 | 6,570 | +69.6% | Form 10-K (filed 2011-02-25) ↗ |
| Q3 2010 | Sep 30, 2010 | 6,260 | +27.7% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 5,992 | +31.8% | Form 10-Q (filed 2010-08-09) ↗ |
| Q1 2010 | Mar 31, 2010 | 6,562 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 3,873 | -20.7% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 4,903 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 4,548 | – | Form 10-Q (filed 2009-08-10) ↗ |
| Q4 2008 | Dec 31, 2008 | 4,886 | – | Form 10-Q (filed 2009-08-10) ↗ |
Cite this data
StockData. (2026). Amgen Total current liabilities ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_cl
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.